The Higher Practice Podcast for Optimal Mental Health cover image

The Business of Psychedelic Therapy - Keith Kurlander & Will Van Derveer

The Higher Practice Podcast for Optimal Mental Health

00:00

MDMA Therapy: A Phase Three Study

The research by the multidisciplinary association for psychedelic studies is at a point where all of the phase three data for efficacy has been collected. People who were assigned to the placebo group during the efficacy part of the trial get the opportunity to crossover. So that data is expected to be complete by the spring of next year. And then we start seeing it come to market, maybe 2025.

Play episode from 43:27
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app